Pneumocystosis and quantitative PCR.

Area of Science:

• Medical Diagnostics
• Infectious Diseases
• Immunology

Background:

• Pneumocystis pneumonia (PCP) is increasingly diagnosed in non-HIV immunosuppressed individuals.
• Traditional direct examination (DE) has limitations in sensitivity for detecting Pneumocystis jirovecii (P. jirovecii).
• Quantitative PCR (qPCR) offers higher sensitivity for P. jirovecii detection.

Purpose of the Study:

• To evaluate the diagnostic contribution of quantitative PCR (qPCR) for Pneumocystis pneumonia (PCP).
• To differentiate between P. jirovecii infection and colonization using qPCR.
• To assess the utility of qPCR in immunosuppressed, non-HIV patients.

Main Methods:

• Retrospective study including patients with suspected PCP and positive qPCR.
• Classification into infection or colonization groups based on clinical, radiological, and microbiological data.
• Comparison of qPCR values between infected and colonized patients.

Main Results:

• 150 patients included (75% non-HIV); 129 diagnosed with PCP.
• Direct examination (DE) was negative in 60% of confirmed PCP cases.
• Median qPCR: 76,650 copies/mL (infection) vs. 3,220 copies/mL (colonization).
• 100% specificity threshold at 56,000 copies/mL; optimal differentiation at 10,100 copies/mL.

Conclusions:

• qPCR is valuable for diagnosing PCP in immunosuppressed patients, particularly when DE is negative.
• qPCR results <56,000 copies/mL necessitate interpretation alongside clinical and paraclinical findings.
• qPCR enhances diagnostic accuracy for PCP in at-risk populations.